Alloimmunity to Human Endothelial Cells Derived from Cord Blood Progenitors

Size: px
Start display at page:

Download "Alloimmunity to Human Endothelial Cells Derived from Cord Blood Progenitors"

Transcription

1 This information is current as of January 15, Alloimmunity to Human Endothelial Cells Derived from Cord Blood Progenitors Yajaira Suárez, Benjamin R. Shepherd, Deepak A. Rao and Jordan S. Pober J Immunol 2007; 179: ; ; doi: /jimmunol References Subscription Permissions Alerts This article cites 45 articles, 31 of which you can access for free at: Why The JI? Submit online. Rapid Reviews! 30 days* from submission to initial decision No Triage! Every submission reviewed by practicing scientists Fast Publication! 4 weeks from acceptance to publication *average Information about subscribing to The Journal of Immunology is online at: Submit copyright permission requests at: Receive free -alerts when new articles cite this article. Sign up at: Downloaded from by guest on January 15, 2019 The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD Copyright 2007 by The American Association of Immunologists All rights reserved. Print ISSN: Online ISSN:

2 The Journal of Immunology Alloimmunity to Human Endothelial Cells Derived from Cord Blood Progenitors 1 Yajaira Suárez, Benjamin R. Shepherd, Deepak A. Rao, and Jordan S. Pober 2 There is considerable interest in exploiting circulating endothelial progenitor cells (EPCs) for therapeutic organ repair. Such cells may be differentiated into endothelial cells (ECs) in vitro and then expanded for use in tissue engineering. Vessel-derived ECs are variably immunogenic, depending upon tissue source, and it is unknown whether ECs derived from cord blood EPCs are able to initiate an allogeneic response. In this study, we compare the phenotype and alloantigenicity of human cord blood progenitor cell-derived ECs with HUVECs isolated from the same donors. Human cord blood progenitor cell-derived ECs are very similar to HUVECs in the expression of proteins relevant for alloimmunity, including MHC molecules, costimulators, adhesion molecules, cytokines, chemokines, and IDO, and in their ability to initiate allogeneic CD4 and CD8 memory T cell responses in vitro and in vivo. These findings have significant implications for the use of cord blood EPCs in regenerative medicine or tissue engineering. The Journal of Immunology, 2007, 179: Both the regeneration of injured tissues and the construction, through bioengineering, of synthetic tissue substitutes depend upon the formation of new blood vessels (1 4). Endothelial cells (ECs) 3 isolated from the luminal lining of mature blood vessels can spontaneously organize into tubes that may serve as the nucleus for new vessel development (3 6). However, vessel-derived ECs have only limited replication potential and rapidly senesce when expanded in vitro (7). ECs may also be differentiated from endothelial progenitors cells (EPCs) that are found in peripheral blood (8). Umbilical cord blood is a particularly rich source of EPCs that can be used for tissue engineering (9, 10). The EPCs found in human cord blood may themselves be heterogeneous. Some EPCs, when cultured in basal medium supplemented with FCS and vascular endothelial growth factor (VEGF), rapidly produce colonies of EC-like cells. These early outgrowth cells express some EC markers, like CD31 or von Willebrand factor, but also express markers of monocytes, like CD14 and CD45. Such cells have limited replicative capacities and do not form stable tubes when implanted in immunodeficient mice (11 13,15). Other EPCs give rise to EC-like colonies only after a delay of 7 days or more (10, 14, 16 21). Such late outgrowth cells have high replicative capacity, express EC but not monocyte markers, and form stable tubes in vivo (14). Hereafter we will refer to the differentiated progeny of late outgrowth EPCs as human cord Department of Immunobiology, Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, CT Received for publication June 26, Accepted for publication September 21, The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 This work was supported in part by National Institute of Health Grants HL-51015, HL85416, and HL and Programme 3 3 Fellowship from the Centro Nacional de Investigaciones Cardiovasculares (CNIC), Spain (to Y.S.). 2 Address correspondence and reprint requests to Dr. Jordan S. Pober, Yale University School of Medicine, 10 Amistad Street, Room 401D, New Haven, CT address: jordan.pober@yale.edu 3 Abbreviations used in this paper: EC, endothelial cell; EPC, endothelial progenitor cell; HUVEC, human umbilical veins; HCBEC, human cord blood progenitor cellderived EC; VEGF, vascular endothelial growth factor; Uea-1, Ulex europeus agglutinin 1; MFI, mean fluorescence intensity. Copyright 2007 by The American Association of Immunologists, Inc /07/$2.00 blood derived ECs (HCBECs). Because of their greater replicative potential and their ability to form stable tubes in vivo, late outgrowth cells are a much more useful source of ECs for therapeutic purposes than early outgrowth EPCs. Immunological rejection of allogeneic stem cells following differentiation represents a major hurdle for both organ regeneration and tissue engineering. This is likely to be particularly true for vascularized structures because some vessel-derived human ECs are capable of initiating an allogeneic immune response, directly presenting both non-self allelic forms of class I and class II MHC molecules to alloreactive memory CD8 and CD4 T cells, respectively (22, 23). Specifically, coculture of purified peripheral blood memory T cells subsets with allogeneic vessel-derived human ECs leads to expression of T cell activation markers, cytokine production, and proliferation (21, 22, 24, 25). Moreover, experiments using immunodeficient mouse hosts have revealed that human ECs are capable of triggering graft rejection by adoptively transferred alloreactive effectors or memory T cells (24). The majority of experiments involving vessel-derived ECs have used either cells isolated from human umbilical veins (HUVEC) or human dermal microvessels. It has been reported that ECs from other vascular beds may differ from HUVECs in their capacities to activate allogeneic T cells (26). It is unknown whether ECs derived from cord blood EPCs are able to activate allogeneic T cells, and if they can do so, how they compare with other types of ECs isolated from mature vessels. In the present study, we have compared HCBECs with HUVECs in a variety of assays for immunological functions. In most instances, we have been able to isolate HCBECs and HUVECs from the same umbilical cord to control for genetic variations. Our key finding is that HCBECs are largely indistinguishable from HUVECs in their expression of molecules of relevance to allogeneic T cell activation and in their ability to stimulate an alloresponse, a result that has important implications for the use of HC- BECs for regenerative medicine or tissue engineering Materials and Methods Cell culture All human cell populations were obtained using protocols approved by the Yale Human Investigation Committee. HUVECs were released from cannulated and perfusion-cleared umbilical veins, by collagenase digestion,

3 The Journal of Immunology 7489 and serially cultured on 0.1% gelatin-coated flasks in M199/20% FBS supplemented with L-glutamine, penicillin/streptomycin (Invitrogen Life Technologies), and endothelial cell growth supplement (Calbiochem) with heparin from porcine intestine as described (27). HCBECs were differentiated from cord blood mononuclear cells in vitro as late outgrowth cells, as previously described (10), and then expanded in culture. Cultures were serially propagated on gelatin-coated flasks in EGM-2/15% FBS and stepwise transitioned to grow in HUVEC culture medium. Cell surface immunostaining ECs were analyzed for surface expression of specific markers by fluorescence flow cytometry. Where indicated, cultured EC were exposed to 10 ng/ml TNF- (R&D Systems) or 50 ng/ml IFN- (BioSource International) for the times specified in the text before harvest. Confluent monolayers were washed twice in HBSS (Invitrogen Life Technologies) and then incubated with trypsin-edta for 1 min. Enzyme activity was then quenched with 20% FBS/M199 and suspended cells were collected and washed in 10 ml of cold 1% BSA (Sigma-Aldrich)/PBS, centrifuged, and washed again in cold 1% BSA/PBS. Cells were then incubated with 2 g/ml primary Ab or isotype control directly conjugated to FITC or PE for 45 min. Immunostained cells were then washed twice with cold PBS and analyzed on a FACSort flow cytometer (BD Biosciences) using CellQuest analysis software collecting 10,000 gated viable cells per sample. Specific Abs used in these analyses were reactive with human CD31, CD45, CD14, HLA-ABC, HLA-DR, CD40, CD80, and CD86 from Beckman Coulter, with CD34 from Miltenyi Biotec, with VEGFR2, glucocorticoid-induced TNF receptor ligand, and E-selectin from R&D Systems, and with CD58 (LFA-3), PD-L1 (CD274), PD-L2 (CD273), 41BB ligand (CD137L), Ox-40 ligand (CD134L), VCAM-1, and ICAM-1 from BD Pharmingen. Anti-human ICOS ligand mab PE-labeled was a gift from H. W. Mages (Forschungs Institut for Molekulare Pharmacologie, Berlin, Germany). Alternatively, cells were stained with FITC-conjugated Ulex europeus agglutinin (Uea-1) (Sigma-Aldrich), which reacts with the blood group ABH expressed on human ECs. Western blot analysis HUVECs or HCBECs were lysed in ice-cold buffer (containing 50 mm Tris-HCl (ph 7.5), 10% glycerol, 125 mm NaCl, 1% Nonidet P-40, 5.3 mm NaF, 1.5 mm Na 2 PO 4 ), 1 mm orthovanadate, 175 mg/ml octylglucopyranoside, 1 mg/ml protease inhibitor mixture (Roche), and 0.25 mg/ml 4-(2-aminoethyl)-benzenesulfonyl fluoride (Roche). Cell lysates were rotated at 4 C for 30 min before the insoluble material was removed by centrifugation at 12,000 g for 10 min. After normalizing for equal protein concentration, cell lysates were heated in SDS sample buffer before separation by SDS-PAGE. Following overnight transfer of the proteins onto nitrocellulose membranes, Western blots were performed using the Table I. mabs reactive with human IDO and Hsp-90 (loading control) from Chemicon International and BD Biosciences, respectively. Cytokine and chemokine assays Supernatants of cultured ECs exposed to 10 ng/ml TNF- (R&D Systems), 50 ng/ml IFN- (BioSource International), or mock-treated for the times specified in the text were collected, and the samples were assessed for IP-10 or IL-8 using ELISA kits from BD Biosciences and BioSource International, respectively. Cell lysates of cultured ECs were prepared as indicated in Western blot analysis section and were used to analyze the expression of IL-1 using an ELISA kit from PeproTech. T cell isolation PBMCs were isolated by density gradient centrifugation of leukapheresis products by using Lymphocyte Separation Medium (Invitrogen Life Technologies) according to the directions of the manufacturer. Isolated PBMCs were stored in 10% DMSO-90% FBS at 196 C, thawed, and washed before use (28). CD4 or CD8 T cells were isolated from PBMCs by positive selection using Dynabeads (Dynal Biotech). The selected population obtained by this procedure was routinely 95% positive for the desired marker by flow cytometry (data not shown). Activated T cells and monocytes were removed by negative selection using an anti-hla-dr mab at a concentration of 5 g/ml (LB3.1; gift of J. Strominger, Harvard University, Cambridge, MA) for 20 min, washed twice, and depleted by using magnetic beads conjugated to goat anti-mouse Ab (Dynal Biotech). Naive and memory subsets of CD4 and CD8 T cells were isolated from the purified T cell subset populations by further negative selection using anti-cd45ro or anti-cd45ra mabs, respectively, at a concentration of 2 g/ml (BioSource International). The selected subset population obtained by this procedure was routinely 95% positive for the nondepleted CD45R isoform by flow cytometry (data not shown). T cell-ec cocultures ECs ( cells) were plated into gelatin-coated wells of 24-well culture plates (Falcon; BD Biosciences) and treated with IFN- (50 ng/ml) (BioSource International) where indicated. Purified T cell subsets were then added to each well ( per well). All cultures were maintained in 5% CO 2 at 37 C. The medium for coculture consisted of RPMI 1640 supplemented with 10% FBS serum, 2 mm L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin all from Invitrogen Life Technologies. Supernatants collected from cocultures of T cells and ECs after the indicated times of coculture were assayed using an ELISA kit for IFN- (BioSource International) or IL-2 (ebioscience). All ELISAs were performed as described by the manufacturers. To measure proliferation by CFSE dilution, CD4 or CD8 T cells were stained with 250 nm CFSE (Molecular Probes) for 20 min before coculture Flow cytometric analysis of proteins of immunological significance in HUVECs and HCBECs isolated from the same donor a HUVEC HCBEC Control IFN (36 h) TNF (6 h) TNF (24 h) Control IFN (36 h) TNF (6 h) TNF (24 h) PECAM-1 (CD31) CD45 ND ND ND ND ND ND ND ND CD14 ND ND ND ND ND ND ND ND HLA-ABC HLA-DR ND 27 ND ND ND 23 ND ND LFA-3 (CD58) CD B7-1 (CD80) ND ND ND ND ND ND ND ND B7-2 (CD86) ND ND ND ND ND ND ND ND ICOS ligand BB ligand (CD137L) Ox40 ligand (CD134L) GITR ligand PD-L1 (CD274) PD-L2 (CD273) VCAM-1 (CD106) ND ICAM-1 (CD54) E-selectin (CD62E) ND a Cells were exposed to 10 ng/ml TNF, 50 ng/ml IFN, or mock treated for the indicated times. Cells were harvested and labeled as described in Materials and Methods. The results are expressed in terms of corrected median fluorescence intensity (MFI), in arbitrary units of fluorescence, after subtracting the MFI of isotype control from the MFI of the specifically stained cells. Each cell type was analyzed from at least two separate cultures with similar results. ND, Not detected.

4 7490 ALLOIMMUNITY TO ENDOTHELIUM FROM CORD BLOOD PROGENITORS FIGURE 1. Time course of surface expression of E-selectin, VCAM-1, and ICAM-1 after cytokine treatment on HCBECs and HUVECs. HUVECs (f) and HCBECs ( ) isolated from the same donor were exposed to 10 ng/ml TNF (continuous line) or 50 ng/ml IFN- (dotted line) for the indicated times. Cells were harvested and labeled as described in Materials and Methods. The results are expressed in terms of corrected MFI, in arbitrary units of fluorescence, after subtracting the MFI of isotype control from the MFI of the specifically stained cells. with EC. Following 1 wk of coculture, T cells were collected and stained with anti-cd4 or CD8 PE-labeled mabs (Beckman Coulter), respectively, and analyzed using two-color FACS. Duplicate samples were labeled with anti-cd25 PE-labeled mab, also from Beckman Coulter. In vivo analysis of EC alloantigenicity All animal protocols were approved by the Yale Institutional Animal Care and Use Committee. Human microvessels were generated and implanted in the s.c. position on the abdominal wall of C.B-17/Scid-beige mice as previously described (5). Briefly, HCBECs or HUVECs were suspended in a rat tail type I collagen-human plasma fibronectin gel and 650 l ofthe cell suspension was gently poured into a single well of a 24-well tissue culture plate. The protein gel was polymerized at 37 C and an equal volume of EGM-2MV was added to the well. Twelve to 18 h after gel polymerization, the gels were removed, bisected, and implanted in the s.c. position on the abdominal wall. Three weeks after implantation, one third of the animals were euthanized and the grafts harvested for analysis of the human microvasculature. A second third of animals were given allogeneic human PBMCs by intraperitoneal inoculation. The remaining animals were injected with PBS and enrolled as nonreconstituted controls. Before the termination of the experiment, the number of circulating human T cells was evaluated. Heparinized retro-orbital venous blood samples were obtained and the erythrocytes were lysed using ammonium chloride. Leukocytes were incubated with PE-conjugated rat anti-mouse CD45 (BD Pharmingen) mab and FITC-conjugated mouse anti-human CD3 mab (Immunotech/Beckman Coulter) in PBS/1% BSA/5% NGS plus 2 g/ml FIGURE 2. Chemokine secretion (IL-8 and IP-10), inflammatory cytokine expression (IL-1 ), and the immunoinhibitory enzyme IDO expression in HUVECs and HCBECs isolated from the same donor. Cells were exposed to 10 ng/ml TNF (u), 50 ng/ml IFN- (F), or mock-treated (E) for 24 h. Supernatants were collected and the samples were assessed for IL-8 (A) or IP-10 (B) using ELISA as described in Materials and Methods. Cells were treated as indicated and cell lysates of cultured ECs were prepared as indicated in Materials and Methods. Lysates analyzed for expression of IL-1 (C) using ELISA and IDO (D) by Western blottign. Hsp-90 protein levels were used as loading control. For panels A C, data represent mean SEM of quadruplicate determinations from one of two independent experiments with similar results. For panel D, blots are from one of two independent experiments with similar results.

5 The Journal of Immunology 7491 FIGURE 3. Activation of CD4 T cells by allogeneic HUVECs and HCBECs isolated from the same donor (donors I and II). HUVECs and HCBECs were treated with IFN- to up-regulate MHC class I/II or mock-treated and subsequently cocultured with CD4 T cells. A and B, Medium were collected for ELISA from HUVECs and HCBECs cultured with CD4 T cells for 24 h. Significant production of both IFN- (A and B, left panels) and IL-2 (A and B, right panels) was observed when compared with resting ECs (not pretreated with IFN- ) orcd4 T cells cultured in the absence of ECs. Data are mean SEM of quadruplicate determinations in one of two independent experiments with similar results. C, After 1 wk of cocultures, CFSE-labeled T cells were stained with anti-cd4 and anti-cd25 mabs and subjected to FACS analysis. CD4 T cells demonstrate significant proliferation in HUVECs or HCBECs cocultures of Donor I and Donor II, as judged by CFSE dilution, and CD25 expression was enhanced in proliferating cells (upper and lower panels, respectively). Data are from one of two independent experiments with similar results. Fc-Block (BD Biosciences) and analyzed by FACS. Three weeks following PBMC inoculation, all remaining mice were euthanized and the grafts harvested for analysis of human EC-lined microvessels and the degree of allogeneic PBMC infiltration. Recovered gels and surrounding soft tissue were fixed in 10% buffered formalin and embedded in paraffin. Sections (5- m thick) were cut for immunostaining and for H&E staining. In some experiments, the harvested grafts were bisected and half of the specimen was fixed in 10% buffered formalin and half snap frozen in Tissue-Tek OCT (Sakura Finetek), the latter used to prepare 6- m cryosections. Sections were also stained with tetramethylrhodamine isothiocyanate-uea-1- labeled lectin for detection of human EC-lined vessels within engrafted protein gels. Statistical analysis All data are expressed as means SEM. Statistical differences were measured by Student s t test. A value of p 0.05 was considered as statistically significant. Results Phenotypic analyses We first characterized multiple individual isolates of both HC- BECs and HUVECs by extensive phenotyping. HCBECs were differentiated from EPCs in vitro as late outgrowth colonies and then serially expanded in culture (10). As we previously reported (10), these HCBECs formed a confluent monolayer of nonoverlapping polygonal cells containing cytoplasmic granules that stained positive for von Willebrand factor and formed intercellular junctions expressing vascular endothelial-cadherin. By flow cytometry, HCBECs uniformly bound Uea-1 and expressed CD34, VEGFR2 and CD31, all markers of differentiated ECs. The HC- BECs used in these experiments were uniformly negative for myeloid markers CD133, CD45, CD18, and CD14 (data not shown), which may be coexpressed by early outgrowth ECs (14). This pattern of lineage marker expression was indistinguishable from that of HUVECs and defines HCBECs as true endothelium. However, compared with HUVECs, HCBECs grew faster (data not shown) and appeared capable of a greater number of population doublings without evidence of senescence, consistent with the growth characteristics previously reported for late outgrowth EPCderived ECs (14, 16, 21). Because of their robust growth potential, HCBECs are of special interest to tissue engineering. Having established that HCBECs appear to be true ECs, we proceeded to analyze the expression of surface proteins of immunological significance under basal conditions and after cytokine (TNF or IFN- ) activation. There is considerable genetic variability among humans in EC expression of molecules of immunological relevance (29). Therefore, six independent isolates were compared and the results were generally consistent with some minor quantitative variations. This extent of variability among donors was comparable to the variability among HUVECs from different donors (data not shown). To compare HCBECs with HUVECs, we isolated three pairs from the same donor, avoiding donor-dependent variability. One representative data set from one of these experiments is shown in Table I. The expression levels in HCBECs of the strongest stimulators of alloimmune response, class I and class II MHC molecules (HLA-ABC and HLA-DR, respectively), were very similar to those in HUVECs, showing only low levels of class I MHC molecules in resting cells and expressing more class I and de novo induction of class II MHC molecules after IFN- treatment (30). Additionally, TNF induced-increases of class I MHC molecules (31) were very similar in both EC types. HCBECs expressed the same set of costimulatory molecules as HUVECs, namely CD58, CD40, ICOS ligand, 4-1BB ligand, Ox40 ligand,

6 7492 ALLOIMMUNITY TO ENDOTHELIUM FROM CORD BLOOD PROGENITORS FIGURE 4. Activation of CD8 T cells by allogeneic HUVECs and HCBECs isolated from the same donor. HUVECs and HCBECs were cocultured with CD8 T cells. A and B, Medium were collected for ELISA from HUVECs and HCBECs cultured with CD8 T cells for 48 h. CD8 T cells cultured with both HUVECs and HCBECs showed significant production of both IFN- (A) and IL-2 (B) when compared with CD8 T cells cultured in the absence of ECs. Data are mean SEM of quadruplicate determinations from one of three independent experiments with similar results. C, After 1 wk of cocultures, CFSE-labeled T cells were stained with anti-cd8 or anti-cd25 mabs and subjected to FACS analysis. CD8 T cells demonstrate significant proliferation in HUVECs and HCBECs cocultures, as judged by CFSE dilution (4.3% and 3.5%, respectively), and the CD25 expression was enhanced in proliferating cells (upper and lower panels, respectively). Data are from one of three independent experiments with similar results. and glucocorticoid-induced TNF receptor ligand, but not CD80 or CD86 (Table I). The levels of expression were generally comparable between HCBECs and HUVECs. The single notable difference being that basal expression of CD40 was consistently lower on HCBECs than on HUVECs, although comparable expression levels were seen after cytokine activation (32). The expression of the negative signaling molecules PD-L1 and PD-L2 on HCBECs were also very similar to HUVECs. We next compared the expression levels of the TNF-induced leukocyte adhesion molecules E-selectin, VCAM-1, and ICAM-1. No significant differences were observed between HCBECs and HUVECs. The pattern and level of expression of these adhesion molecules following either TNF or IFN- treatment was analyzed in a time course experiment and found to be similar between both cell types (Fig. 1). Cumulatively, these data suggest that HCBECs express the same pattern of surface molecules relevant for interactions with the immune system as HUVECs. Many soluble factors secreted by ECs may also contribute to allogeneic responses. Therefore, we analyzed the EC secretion of some of these proteins including cytokine-induced proinflammatory chemokines (IL-8 and IP-10) and the inflammatory cytokine (IL-1 ) (in our hands HUVECS synthesize very little IL- and do not synthesize TNF (33) and unpublished data). As shown in Fig. 2, A and B, the secretion of IL-8 and IP-10 in response to TNF and IFN-, respectively, was very similar in both cell types and among different donors. The levels of IL-1 after TNF treatment were also very similar in both cell types but varied more highly among donors (Fig. 2C). We also examined the expression of the immunoinhibitory enzyme IDO, which may play a role in the regulation of adaptive immune responses (26, 34). The level of expression of IDO was undetectable under basal conditions but was induced to comparable levels in both cell types following IFN- treatment (Fig. 2D). Additionally, when the surface expression of CD95L (FasL) was analyzed under basal conditions and after cytokine treatment, no detectable expression was found in either cell type (data not shown). Functional analyses in vitro Cultured HUVECs can present both class I and class II MHC molecules in a manner that results in the activation of allogeneic memory T cells (25, 35). We analyzed the responses of multiple T cell isolates from adult human peripheral blood to multiple different cultures of HCBECs and HUVECs and found generally similar responses to both cell types (data not shown). Once again, to avoid differences attributable to different donor origin we focused our experiments on the response of T cells to pairs of HCBECs and HUVECs isolated from the same EC donors, and the results from two independent donors are shown in Fig. 3. In these experiments with CD4 T cells, HUVECs and HCBECs were first treated with IFN- for three days (to induce HLA-DR expression) or mocktreated and then cocultured with allogeneic, CFSE-labeled CD4 T cells. Untreated (HLA-DR ) HUVECs and HCBECs from both donor I and II were less able to induce CD4 T cells to secrete either IFN- or IL-2 (Fig. 3, A and B). In contrast, both types of ECs that had been pretreated with IFN- induced significant production of these two cytokines in cocultures with allogeneic CD4 T cells (Fig. 3, A and B). The overall degree of secretion of both cytokines by CD4 T cells was higher in response to donor I than in donor II. Although cytokine secretion by T cells stimulated with EC from donor I was slightly less in HCBEC cocultures than in HUVEC cocultures (Fig. 3A, left and right panels), this difference was not observed in cocultures donor II (Fig. 3B, left and right panels). Consistent with IL-2 secretion, CD4 T cells demonstrate both proliferation and activation in response to IFN- -pretreated HUVECs or HCBECs from both donor I and II, as judged by CFSE dilution and CD25 expression in proliferating cells, respectively (Fig. 3C, upper and lower panels). Again, the degree of the T cell response was higher in cocultures with ECs from donor I

7 The Journal of Immunology and HCBEC cocultures from this donor were less able to activate CD4 T cells than HUVEC cocultures from this same donor. This difference was less clear in ECs from donor II. These results show that HCBECs are roughly comparable to HUVECs in their ability to activate allogeneic CD4 T cells. We next compared the capacity of HCBECs to activate allogeneic CD8 T cells. As shown in Fig. 3, resting HCBECs were able to induce CD8 T cells to secrete IFN- and IL-2 (Fig. 4, A and B) and to proliferate (Fig. 4C). As expected, similar percentages of proliferating cells were found when activated cells were analyzed (CD25 high and CFSE low ) (Fig. 4C, lower panels). The CD8 T cell response to HCBECs was similar to the response to HUVECs in the same experiments. HUVECs preferentially activated allogeneic memory T cells compared with naive T cells (22, 23). To assess whether HCBECs 7493 also share this characteristic, allogeneic CD4 and CD8 T cells were first separated into memory (CD45RO ) and naive (CD45RA ) T cells and then separately cocultured with HCBECs or HUVECs (Fig. 5). As shown in Fig. 4, A and B, CD4 T cells (memory and naive) did not respond to HUVECs or HCBECs that were not pretreated with IFN-, but IFN- pretreated HUVEC and HCBECs were both able to induce memory (CD45RO ) but not naive (CD45RA ) CD4 T cells to secrete IFN- and IL-2. By CFSE dilution and FACS analysis, purified memory CD4 T cells, but not naive CD4 T cells, proliferated in cocultures with IFN- pretreated HUVECs and HCBECs (Fig. 5C). Similarly, only memory CD8 T cells were induced to secrete IFN- and IL-2 (Fig. 5, D and E) and to proliferate significantly (Fig. 5F) in response to allogeneic HUVECs or HCBECs, but in this case IFN- pretreatment was not required. The overall magnitude of T cell responses FIGURE 5. HUVECs and HCBECs activate CD4 and CD8 T cells memory but not naive T cells. A C, HUVECs and HCBECs were treated with IFN- as previously indicated and subsequently cocultured with CD4 T memory (CD45RO ) or naive (CD45RA ) T cells. A and B, Media were collected for ELISA from HUVECs and HCBECs cultured with either memory or naive CD4 T cells for 24 h. Memory CD4 T cells cultured with both HUVECs and HCBECs showed significant production of both IFN- (A) and IL-2 (B) when compared with naive CD4 T or when compared with resting ECs (not pretreated with IFN- ) or memory and naive CD4 T cells cultured in the absence of ECs. Data are mean SEM of quadruplicate determinations from one of two independent experiments with similar results. C, After 1 wk of cocultures, purified CFSE-labeled CD4 memory and naive T cells were stained with anti-cd4 mab and subjected to FACS analysis. Purified memory CD4 T cells showed significantly greater proliferation than their purified naive counterparts in HUVECs and HCBECs cocultures. Data are from one of two independent experiments with similar results. D F, HUVECs and HCBECs were cocultured with CD8 memory (CD45RO ) or naive (CD45RA ) T cells. D and E, Media were collected for ELISA from HUVECs and HCBECs cultured either memory or naive CD8 T cells for 48 h. Memory CD8 T cells cultured with both HUVECs and HCBECs showed significant production of both IFN- (A) and IL-2 (B) when compared with naive CD8 T cells or memory and naive CD8 T cells cultured in the absence of ECs. Data are mean SEM of quadruplicates determinations from one of two independent experiments with similar results. E, After 1 wk of cocultures, CFSE-labeled T cells were stained with anti-cd8 mab and subjected to FACS analysis. Purified memory CD8 T cells showed greater proliferation than their purified naive counterparts in HUVECs and HCBECs cocultures. Data are from one of two independent experiments with similar results.

8 7494 ALLOIMMUNITY TO ENDOTHELIUM FROM CORD BLOOD PROGENITORS to HCBECs were somewhat less than those elicited by allogeneic HUVECs, but differences did not reach statistical significance in multiple comparisons. To determine whether the variably lesser degree of stimulation induced by HCBECs from donor I correlated with the slightly higher level of expression of the IFN- -induced IDO (Fig. 2D), we either inhibited IDO activity with 1-methyl- (D)-tryptophan (200 M) or supplemented the cocultures with tryptophan (200 M). Neither of these strategies increased the ability of HCBECs (or HUVECs) to further stimulate T cell proliferation (data not shown). FIGURE 6. HUVECs and HCBECs are subjected to T cell-mediated rejection in vivo. A, H&E staining of collagen-fibronectin gels containing either HCBECs or HUVECs. Stable, perfused, microvessels were formed at 3 wk by either HCBECs or HUVECs in protein gels following s.c. implantation in immunodeficient mice (left panels) and were found to persist for at least 6 wk (middle panels). Three weeks after implantation, the remaining animals were reconstituted with PBMCs or given saline. Three weeks after reconstitution, vessel destruction was noted in gels containing either HCBECs or HUVECs in animals receiving PBMCs (right panels), but not saline injected controls (central panels). B, Quantification of human vessel density, calculated as Uea-1 positive staining per gel area in arbitrary units. For each animal, 2 4 randomly selected fields ( 20) from two sections were quantified; n 3., p 0.05 Functional analyses in vivo In a final series of experiments, we evaluated the interactions between allogeneic lymphocytes and human EC-lined microvessels in vivo using a previously described model. Specifically, human ECs were suspended in proteins gels formed from rat tail type I collagen and human plasma fibronectin (5, 36, 37) and then implanted into the abdominal wall of C.B-17/SCID-beige mouse. Consistent with previous reports, implanted HUVECs and HCBECs will form tubes that inosculate with the host vasculature and are perfused with mouse blood (Fig. 6A) (5, 14). Perfused tubes are established by 3 wk and persist for as long as 6 wk (Fig. 6A). To detect T cell-mediated alloreactivity in vivo, 3 wk after implantation of collagen-fibronectin gels containing HUVECs or HCBECs, some of the animals were inoculated i.p. with PBMC allogeneic to the HUVECs or HCBECs lining the developed human microvessels. The remaining animals were injected with saline as control groups. All grafts were harvested 3 wk later. Grafts containing either HCBECs or HUVECs showed a plexus of simple EC-lined tubes containing mouse blood at 3 wk postimplantation and the appearance at 6 wk was largely unchanged in animals inoculated with saline (Fig. 6A, left and center panels). Inoculation with PBMCs led similar changes in grafts formed from HCBECs or HUVECs, namely loss of tubes, a sparse inflammatory infiltrate comprised of mononuclear cells, and focal areas of calcification (Fig. 6A, right panels). Immunostaining identified only rare human CD45 cells within the gel, although focal accumulations were noted at the edge of the gel in some specimens (data not shown). Staining of human ECs with Uea-1 lectin confirmed previous results with HUVECs that the perfused tubes within the gels of control animals were lined with human ECs and that human ECs disappeared in animals receiving allogeneic human PBMCs (5, 36, 37). Quantitation of Uea-1 staining revealed that the number of human EC-lined tubes increased between 3 and 6 wk in saline inoculated animals, but were decreased in animals receiving PBMCs (Fig. 6B). Significantly, no differences were observed in this in vivo model of human graft rejection between gels containing HCBECs or gels containing HUVECs. Discussion Previous reports have shown that human EPCs isolated from peripheral blood or umbilical cord blood can be differentiated to mature ECs and expanded in vitro, providing a robust source of ECs for cell transplantation and for promoting vascularization of tissue engineered organs and tissues (38 44). In theory, the expansion of vascular cells from blood progenitors could allow patients to serve as their own (autologous) stem cell donors, minimizing the potential for immunological rejection. However, most indications for the use of allogeneic sources of ECs will of necessity be derived from allogeneic stem cell sources, e.g., in the treatment of acute ischemic events or in the prefabrication of bioengineered tissues for clinical use. Moreover, cord blood EPCs appear more robust than EPCs from peripheral blood of adults and most adult recipients will not have access to autologous cord blood. Differentiation and expansion of ECs from allogeneic EPCs will give rise to alloantigenic differences between donor and recipient. Before this study, the significance of such differences for graft survival was unknown. It has been demonstrated that differentiated ECs isolated from mature blood vessels, such as HUVECs, are immunogenic,

9 The Journal of Immunology 7495 stimulating nonself (allogeneic) memory T cells to proliferate, differentiate, and produce effector cytokines (25, 35). Remarkably, there are no previous data comparing the capacities of circulating EPC-derived ECs with their counterparts isolated from mature blood vessels with regard to stimulating alloreactive T cells (45), the principal mediators of allograft rejection. The present study was conducted to address this question. We (10) and others (14, 16, 21) have demonstrated that late outgrowth EPCs from cord blood efficiently differentiate into ECs, and HCBECs appear to behave in a manner, except from their greater proliferative potential, that is indistinguishable from ECs isolated from a vessel wall such as HUVECs assessed by morphology, lineage markers, and tube formation capacity in vivo. In the present study, we show that HCBECs express essentially the same pattern of immunologically relevant molecules as HUVECs, including class I and class II MHC molecules, costimulators, adhesion molecules, cytokines, and chemokines under basal conditions and after cytokine stimulation. We also found that HCBECs are generally comparable to HUVECs in their ability to activate allogeneic memory CD4 and CD8 T cells, assessed by cytokine production and proliferation, although HCBECs may be slightly less efficient than HUVECs at eliciting these T cell responses in vitro. The IDO-mediated immunoinhibitory response was not responsible for this difference. We confirm that HCBECs possess a similar capacity as HUVECs to generate perfused human microvessel-like structures when incorporated in a collagen-fibronectin gel and implanted in the s.c. position on the abdominal wall of immunocompromised mice. We did confirm that when mice that had received microvascular grafts prepared from HUVECs were reconstituted with human PBMCs allogeneic to the cells used to generate the human microvascular tissue, the vessels were subjected to PBMC-mediated vessel destruction (37). Unpublished studies (J. S. Pober and A. L. M. Bothwell) using T cells primed by coculture with allogeneic ECs suggested that vessel destruction in this model is likely the result of an allogeneic response. In the present study, we found that vessel destruction was indistinguishable when the grafts were constructed with HCBECs or with HUVECs. Cumulatively, these findings establish that ECs differentiated from EPCs are immunogenic and indicate that they will likely be rejected by the immune system if used for cell therapy and/or tissue engineering. Our findings suggest that EPCs will need to be obtained from MHC-matched donors to reduce alloantigenicity. Alternatively, it may be possible to genetically alter such cells to reduce their capacity to activate T cells. Acknowledgments We thank Louise Benson, Gwen Davis, and Lisa Gras for assistance with cell culture and animal care, and Dr. Edward Snyder and the Yale Blood Bank for assistance with leukaphereses. Disclosures The authors have no financial conflict of interest. References 1. Carmeliet, P Angiogenesis in life, disease and medicine. Nature 438: Jain, R. K Molecular regulation of vessel maturation. Nat. Med. 9: Folkman, J Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: Conway, E. M., D. Collen, and P. Carmeliet Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49: Schechner, J. S., A. K. Nath, L. Zheng, M. S. Kluger, C. C. Hughes, M. R. Sierra-Honigmann, M. I. Lorber, G. Tellides, M. Kashgarian, A. L. Bothwell, and J. S. Pober In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc. Natl. Acad. Sci. USA 97: Enis, D. R., B. R. Shepherd, Y. Wang, A. Qasim, C. M. Shanahan, P. L. Weissberg, M. Kashgarian, J. S. Pober, and J. S. Schechner Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl- 2-transduced endothelial cells. Proc. Natl. Acad. Sci. USA 102: Garfinkel, S., S. Brown, J. H. Wessendorf, and T. Maciag Post-transcriptional regulation of interleukin 1 in various strains of young and senescent human umbilical vein endothelial cells. Proc. Natl. Acad. Sci. USA 91: Asahara, T., T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, and J. M. Isner Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: Kaushal, S., G. E. Amiel, K. J. Guleserian, O. M. Shapira, T. Perry, F. W. Sutherland, E. Rabkin, A. M. Moran, F. J. Schoen, A. Atala, et al Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 7: Shepherd, B. R., D. R. Enis, F. Wang, Y. Suarez, J. S. Pober, and J. S. Schechner Vascularization and engraftment of a human skin substitute using circulating progenitor cell-derived endothelial cells. FASEB J. 20: Zhao, Y., D. Glesne, and E. Huberman A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc. Natl. Acad. Sci. USA 100: Schmeisser, A., C. D. Garlichs, H. Zhang, S. Eskafi, C. Graffy, J. Ludwig, R. H. Strasser, and W. G. Daniel Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc. Res. 49: Fernandez Pujol, B., F. C. Lucibello, U. M. Gehling, K. Lindemann, N. Weidner, M. L. Zuzarte, J. Adamkiewicz, H. P. Elsasser, R. Muller, and K. Havemann Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65: Yoder, M. C., L. E. Mead, D. Prater, T. R. Krier, K. N. Mroueh, F. Li, R. Krasich, C. J. Temm, J. T. Prchal, and D. A. Ingram Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: Rehman, J., J. Li, C. M. Orschell, and K. L. March Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: Ingram, D. A., N. M. Caplice, and M. C. Yoder Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106: Ingram, D. A., L. E. Mead, D. B. Moore, W. Woodard, A. Fenoglio, and M. C. Yoder Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105: Ingram, D. A., L. E. Mead, H. Tanaka, V. Meade, A. Fenoglio, K. Mortell, K. Pollok, M. J. Ferkowicz, D. Gilley, and M. C. Yoder Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: Hur, J., C. H. Yoon, H. S. Kim, J. H. Choi, H. J. Kang, K. K. Hwang, B. H. Oh, M. M. Lee, and Y. B. Park Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24: Gulati, R., D. Jevremovic, T. E. Peterson, S. Chatterjee, V. Shah, R. G. Vile, and R. D. Simari Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93: Bompais, H., J. Chagraoui, X. Canron, M. Crisan, X. H. Liu, A. Anjo, C. Tolla-Le Port, M. Leboeuf, P. Charbord, A. Bikfalvi, and G. Uzan Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 103: Epperson, D. E., and J. S. Pober Antigen-presenting function of human endothelial cells: direct activation of resting CD8 T cells. J. Immunol. 153: Marelli-Berg, F. M., L. Frasca, L. Weng, G. Lombardi, and R. I. Lechler Antigen recognition influences transendothelial migration of CD4 T cells. J. Immunol. 162: Shiao, S. L., J. M. McNiff, and J. S. Pober Memory T cells and their costimulators in human allograft injury. J. Immunol. 175: Ma, W., and J. S. Pober Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4 T cells. J. Immunol. 161: Beutelspacher, S. C., P. H. Tan, M. O. McClure, D. F. Larkin, R. I. Lechler, and A. J. George Expression of 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am. J. Transplant. 6: Gimbrone, M. A., Jr., R. S. Cotran, and J. Folkman Human vascular endothelial cells in culture: growth and DNA synthesis. J. Cell Biol. 60: Kirkiles-Smith, N. C., K. Mahboubi, J. Plescia, J. M. McNiff, J. Karras, J. S. Schechner, D. C. Altieri, and J. S. Pober IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression. J. Immunol. 172: Bender, J. R., M. M. Sadeghi, C. Watson, S. Pfau, and R. Pardi Heterogeneous activation thresholds to cytokines in genetically distinct endothelial cells: evidence for diverse transcriptional responses. Proc. Natl. Acad. Sci. USA 91: Pober, J. S., T. Collins, M. A. Gimbrone, Jr., R. S. Cotran, J. D. Gitlin, W. Fiers, C. Clayberger, A. M. Krensky, S. J. Burakoff, and C. S. Reiss Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305:

10 7496 ALLOIMMUNITY TO ENDOTHELIUM FROM CORD BLOOD PROGENITORS 31. Collins, T., L. A. Lapierre, W. Fiers, J. L. Strominger, and J. S. Pober Recombinant human tumor necrosis factor increases mrna levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc. Natl. Acad. Sci. USA 83: Karmann, K., C. C. Hughes, J. Schechner, W. C. Fanslow, and J. S. Pober CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92: Kurt-Jones, E. A., W. Fiers, and J. S. Pober Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J. Immunol. 139: Mellor, A. L., and D. H. Munn IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: Dengler, T. J., D. R. Johnson, and J.S. Pober Human vascular endothelial cells stimulate a lower frequency of alloreactive CD8 pre-ctl and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes. J. Immunol. 166: Zheng, L., T. J. Dengler, M. S. Kluger, L. A. Madge, J. S. Schechner, S. E. Maher, J. S. Pober, and A. L. Bothwell Cytoprotection of human umbilical vein endothelial cells against apoptosis and CTL-mediated lysis provided by caspase-resistant Bcl-2 without alterations in growth or activation responses. J. Immunol. 164: Zheng, L., T. F. Gibson, J. S. Schechner, J. S. Pober, and A. L. Bothwell Bcl-2 transduction protects human endothelial cell synthetic microvessel grafts from allogeneic T cells in vivo. J. Immunol. 173: Griese, D. P., A. Ehsan, L. G. Melo, D. Kong, L. Zhang, M. J. Mann, R. E. Pratt, R. C. Mulligan, and V. J. Dzau Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108: Assmus, B., V. Schachinger, C. Teupe, M. Britten, R. Lehmann, N. Dobert, F. Grunwald, A. Aicher, C. Urbich, H. Martin, et al Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106: Kalka, C., H. Masuda, T. Takahashi, W. M. Kalka-Moll, M. Silver, M. Kearney, T. Li, J. M. Isner, and T. Asahara Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97: Kawamoto, A., H. C. Gwon, H. Iwaguro, J. I. Yamaguchi, S. Uchida, H. Masuda, M. Silver, H. Ma, M. Kearney, J. M. Isner, and T. Asahara Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: Kocher, A. A., M. D. Schuster, M. J. Szabolcs, S. Takuma, D. Burkhoff, J. Wang, S. Homma, N. M. Edwards, and S. Itescu Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7: Pesce, M., A. Orlandi, M. G. Iachininoto, S. Straino, A. R. Torella, V. Rizzuti, G. Pompilio, G. Bonanno, G. Scambia, and M. C. Capogrossi Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ. Res. 93: e51 e Shirota, T., H. Yasui, H. Shimokawa, and T. Matsuda Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 24: Fang, T. C., M. R. Alison, N. A. Wright, and R. Poulsom Adult stem cell plasticity: will engineered tissues be rejected? Int. J. Exp. Pathol. 85:

Ex vivo Human Antigen-specific T Cell Proliferation and Degranulation Willemijn Hobo 1, Wieger Norde 1 and Harry Dolstra 2*

Ex vivo Human Antigen-specific T Cell Proliferation and Degranulation Willemijn Hobo 1, Wieger Norde 1 and Harry Dolstra 2* Ex vivo Human Antigen-specific T Cell Proliferation and Degranulation Willemijn Hobo 1, Wieger Norde 1 and Harry Dolstra 2* 1 Department of Laboratory Medicine - Laboratory of Hematology, Radboud University

More information

Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD-

Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD- Supplementary Methods Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD- L1 (10F.9G2, rat IgG2b, k), and PD-L2 (3.2, mouse IgG1) have been described (24). Anti-CTLA-4 (clone

More information

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice Supplementary figure legends Supplementary Figure 1. Characterization of after reconstitution of SCID mice with CD4 + CD62L + T cells. (A-C) SCID mice (n = 6 / group) were reconstituted with 2 x 1 6 CD4

More information

Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells

Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells Research article Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells Chen Wang, 1 Tai Yi, 1 Lingfeng Qin, 2 Roberto A. Maldonado, 3 Ulrich H. von Andrian, 3

More information

Detailed step-by-step operating procedures for NK cell and CTL degranulation assays

Detailed step-by-step operating procedures for NK cell and CTL degranulation assays Supplemental methods Detailed step-by-step operating procedures for NK cell and CTL degranulation assays Materials PBMC isolated from patients, relatives and healthy donors as control K562 cells (ATCC,

More information

PBMC from each patient were suspended in AIM V medium (Invitrogen) with 5% human

PBMC from each patient were suspended in AIM V medium (Invitrogen) with 5% human Anti-CD19-CAR transduced T-cell preparation PBMC from each patient were suspended in AIM V medium (Invitrogen) with 5% human AB serum (Gemini) and 300 international units/ml IL-2 (Novartis). T cell proliferation

More information

Suppl Video: Tumor cells (green) and monocytes (white) are seeded on a confluent endothelial

Suppl Video: Tumor cells (green) and monocytes (white) are seeded on a confluent endothelial Supplementary Information Häuselmann et al. Monocyte induction of E-selectin-mediated endothelial activation releases VE-cadherin junctions to promote tumor cell extravasation in the metastasis cascade

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Complete but curtailed T-cell response to very-low-affinity antigen Dietmar Zehn, Sarah Y. Lee & Michael J. Bevan Supp. Fig. 1: TCR chain usage among endogenous K b /Ova reactive T cells. C57BL/6 mice

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/23854 holds various files of this Leiden University dissertation. Author: Marel, Sander van der Title: Gene and cell therapy based treatment strategies

More information

VEGFR2-Mediated Vascular Dilation as a Mechanism of VEGF-Induced Anemia and Bone Marrow Cell Mobilization

VEGFR2-Mediated Vascular Dilation as a Mechanism of VEGF-Induced Anemia and Bone Marrow Cell Mobilization Cell Reports, Volume 9 Supplemental Information VEGFR2-Mediated Vascular Dilation as a Mechanism of VEGF-Induced Anemia and Bone Marrow Cell Mobilization Sharon Lim, Yin Zhang, Danfang Zhang, Fang Chen,

More information

CONTRACTING ORGANIZATION: Johns Hopkins University School of Medicine Baltimore, MD 21205

CONTRACTING ORGANIZATION: Johns Hopkins University School of Medicine Baltimore, MD 21205 AD Award Number: DAMD7---7 TITLE: Development of Artificial Antigen Presenting Cells for Prostate Cancer Immunotherapy PRINCIPAL INVESTIGATOR: Jonathan P. Schneck, M.D., Ph.D. Mathias Oelke, Ph.D. CONTRACTING

More information

SUPPLEMENTARY INFORMATION. Involvement of IL-21 in the epidermal hyperplasia of psoriasis

SUPPLEMENTARY INFORMATION. Involvement of IL-21 in the epidermal hyperplasia of psoriasis SUPPLEMENTARY INFORMATION Involvement of IL-21 in the epidermal hyperplasia of psoriasis Roberta Caruso 1, Elisabetta Botti 2, Massimiliano Sarra 1, Maria Esposito 2, Carmine Stolfi 1, Laura Diluvio 2,

More information

Cytotoxic T lymphocytes reactive with endothelium have

Cytotoxic T lymphocytes reactive with endothelium have Human Vascular Endothelial Cells Stimulate Memory But Not Naive CD8 T Cells to Differentiate into CTL Retaining an Early Activation Phenotype 1 Thomas J. Dengler and Jordan S. Pober 2 Endothelial cell

More information

Primary Adult Naïve CD4+ CD45RA+ Cells. Prepared by: David Randolph at University of Alabama, Birmingham

Primary Adult Naïve CD4+ CD45RA+ Cells. Prepared by: David Randolph at University of Alabama, Birmingham Primary Adult Naïve CD4+ CD45RA+ Cells Prepared by: David Randolph (drdrdr@uab.edu) at University of Alabama, Birmingham Goal: To obtain large numbers of highly pure primary CD4+ CD45RO- CD25- cells from

More information

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes

More information

Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas

Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas Chapter 04: Antigen Recognition in the Adaptive Immune System Test Bank MULTIPLE CHOICE 1. Most T lymphocytes

More information

CHAPTER 3 LABORATORY PROCEDURES

CHAPTER 3 LABORATORY PROCEDURES CHAPTER 3 LABORATORY PROCEDURES CHAPTER 3 LABORATORY PROCEDURES 3.1 HLA TYPING Molecular HLA typing will be performed for all donor cord blood units and patients in the three reference laboratories identified

More information

NK cell flow cytometric assay In vivo DC viability and migration assay

NK cell flow cytometric assay In vivo DC viability and migration assay NK cell flow cytometric assay 6 NK cells were purified, by negative selection with the NK Cell Isolation Kit (Miltenyi iotec), from spleen and lymph nodes of 6 RAG1KO mice, injected the day before with

More information

Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to

Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to Class II tetramer staining Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to PE were combined with dominant HIV epitopes (DRB1*0101-DRFYKTLRAEQASQEV, DRB1*0301- PEKEVLVWKFDSRLAFHH,

More information

Supporting Information

Supporting Information Supporting Information Bellora et al. 10.1073/pnas.1007654108 SI Materials and Methods Cells. NK cells purified from peripheral blood mononuclear cells (PBMC) of healthy donors (Human NK Cell Isolation

More information

Cytomegalovirus is a nearly ubiquitous and persistent

Cytomegalovirus is a nearly ubiquitous and persistent Cytomegalovirus-Infected Human Endothelial Cells Can Stimulate Allogeneic CD4 Memory T Cells by Releasing Antigenic Exosomes 1 Jason D. Walker,* Cheryl L. Maier, and Jordan S. Pober 2 Human CMV infection

More information

Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features

Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features Loretta Gammaitoni, Lidia Giraudo, Valeria Leuci, et al. Clin Cancer Res

More information

ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY

ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY ACTIVATION OF T LYMPHOCYTES AND CELL MEDIATED IMMUNITY The recognition of specific antigen by naïve T cell induces its own activation and effector phases. T helper cells recognize peptide antigens through

More information

Supplementary Materials for

Supplementary Materials for immunology.sciencemag.org/cgi/content/full/2/16/eaan6049/dc1 Supplementary Materials for Enzymatic synthesis of core 2 O-glycans governs the tissue-trafficking potential of memory CD8 + T cells Jossef

More information

CD34 + VEGFR-3 + progenitor cells have a potential to differentiate towards lymphatic endothelial cells

CD34 + VEGFR-3 + progenitor cells have a potential to differentiate towards lymphatic endothelial cells CD34 + VEGFR-3 + progenitor cells have a potential to differentiate towards lymphatic endothelial cells Tan YZ et al. J Cell Mol Med. (2014 Mar;18(3):422-33) Denise Traxler-Weidenauer April 2014 Introduction

More information

Supplementary Materials. for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis

Supplementary Materials. for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis Supplementary Materials for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis 1 Supplementary Figure Legends Supplementary Figure 1: Integrin expression

More information

McAb and rhil-2 activated bone marrow on the killing and purging of leukemia cells

McAb and rhil-2 activated bone marrow on the killing and purging of leukemia cells Effects of McAb and rhil-2 activated bone marrow on the killing and purging of leukemia cells X.C. Wei, D.D. Yang, X.R. Han, Y.A. Zhao, Y.C. Li, L.J. Zhang and J.J. Wang Institute of hematological research,

More information

Blocking MHC class II on human endothelium mitigates acute rejection

Blocking MHC class II on human endothelium mitigates acute rejection Downloaded from http:// on April 6, 2018. https://doi.org/10.1172/jci.insight.85293 Blocking MHC class II on human endothelium mitigates acute rejection Parwiz Abrahimi, 1 Lingfeng Qin, 2 William G. Chang,

More information

Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis

Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis Vincent Laufer Rheumatology JC October 17 Disclosures NIH 2

More information

Mesenchymal Stem Cells

Mesenchymal Stem Cells Mesenchymal Stem Cells Science and therapeutic applications Dirk Büscher (Former VP-R&D Cellerix) GRIFOLS SA May 10 th, 2010 EMA 1 Discovery and Definition of Mesenchymal Stem Cells MSC must be plastic-adherent

More information

Supplementary Data. Treg phenotype

Supplementary Data. Treg phenotype Supplementary Data Additional Experiment An additional experiment was performed using cryopreserved peripheral blood mononuclear cells (PBMC) derived from five renal cell carcinoma (RCC) patients [see

More information

In vitro bactericidal assay Fig. S8 Gentamicin protection assay Phagocytosis assay

In vitro bactericidal assay Fig. S8 Gentamicin protection assay Phagocytosis assay In vitro bactericidal assay Mouse bone marrow was isolated from the femur and the tibia. Cells were suspended in phosphate buffered saline containing.5% BSA and 2 mm EDTA and filtered through a cell strainer.

More information

MATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All

MATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All MATERIALS AND METHODS Antibodies (Abs), flow cytometry analysis and cell lines Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All other antibodies used

More information

Supplementary Fig. 1 p38 MAPK negatively regulates DC differentiation. (a) Western blot analysis of p38 isoform expression in BM cells, immature DCs

Supplementary Fig. 1 p38 MAPK negatively regulates DC differentiation. (a) Western blot analysis of p38 isoform expression in BM cells, immature DCs Supplementary Fig. 1 p38 MAPK negatively regulates DC differentiation. (a) Western blot analysis of p38 isoform expression in BM cells, immature DCs (idcs) and mature DCs (mdcs). A myeloma cell line expressing

More information

CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases

CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases Jun Hee Lee, Sang Hun Lee, So Young Yoo, Takayuki Asahara, Sang Mo Kwon Downloaded

More information

Cellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU

Cellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU Cellular Immune response Jianzhong Chen, Ph.D Institute of immunology, ZJU Concept of adaptive immune response T cell-mediated adaptive immune response I. Concept of immune response A collective and coordinated

More information

Direct ex vivo characterization of human antigen-specific CD154 + CD4 + T cells Rapid antigen-reactive T cell enrichment (Rapid ARTE)

Direct ex vivo characterization of human antigen-specific CD154 + CD4 + T cells Rapid antigen-reactive T cell enrichment (Rapid ARTE) Direct ex vivo characterization of human antigen-specific CD154 + CD4 + T cells Rapid antigen-reactive T cell enrichment (Rapid ARTE) Introduction Workflow Antigen (ag)-specific T cells play a central

More information

HCC1937 is the HCC1937-pcDNA3 cell line, which was derived from a breast cancer with a mutation

HCC1937 is the HCC1937-pcDNA3 cell line, which was derived from a breast cancer with a mutation SUPPLEMENTARY INFORMATION Materials and Methods Human cell lines and culture conditions HCC1937 is the HCC1937-pcDNA3 cell line, which was derived from a breast cancer with a mutation in exon 20 of BRCA1

More information

Data Sheet TIGIT / NFAT Reporter - Jurkat Cell Line Catalog #60538

Data Sheet TIGIT / NFAT Reporter - Jurkat Cell Line Catalog #60538 Data Sheet TIGIT / NFAT Reporter - Jurkat Cell Line Catalog #60538 Background: TIGIT is a co-inhibitory receptor that is highly expressed in Natural Killer (NK) cells, activated CD4+, CD8+ and regulatory

More information

Rapid antigen-specific T cell enrichment (Rapid ARTE)

Rapid antigen-specific T cell enrichment (Rapid ARTE) Direct ex vivo characterization of human antigen-specific CD154+CD4+ T cell Rapid antigen-specific T cell enrichment (Rapid ARTE) Introduction Workflow Antigen (ag)-specific T cells play a central role

More information

DECLARATION OF CONFLICT OF INTEREST. No conflicts of interest

DECLARATION OF CONFLICT OF INTEREST. No conflicts of interest DECLARATION OF CONFLICT OF INTEREST No conflicts of interest University Heart Centre Tübingen Angiogenic actions of platelets Meinrad Gawaz, MD, FESC Tübingen, Germany ESC 2011 Paris GPIb GPIb GPVI TxA2

More information

CD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow

CD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow White Paper September 2016 CD34+ Cells: A Comparison of Stem and Progenitor Cells in Cord Blood, Peripheral Blood, and the Bone Marrow Lily C. Trajman, PhD Introduction: Hematopoietic Stem Cells (HSCs)

More information

MECHANISMS OF CELLULAR REJECTION IN ORGAN TRANSPLANTATION AN OVERVIEW

MECHANISMS OF CELLULAR REJECTION IN ORGAN TRANSPLANTATION AN OVERVIEW MECHANISMS OF CELLULAR REJECTION IN ORGAN TRANSPLANTATION AN OVERVIEW YVON LEBRANCHU Service Néphrologie et Immunologie Clinique CHU TOURS ANTIGEN PRESENTING CELL CD4 + T CELL CYTOKINE PRODUCTION CLONAL

More information

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214,

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214, Adaptive Immunity Jeffrey K. Actor, Ph.D. MSB 2.214, 500-5344 Lecture Objectives: Understand role of various molecules including cytokines, chemokines, costimulatory and adhesion molecules in the development

More information

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS 1 Antigen Presentation and T Lymphocyte Activation Abul K. Abbas UCSF FOCiS 2 Lecture outline Dendritic cells and antigen presentation The role of the MHC T cell activation Costimulation, the B7:CD28 family

More information

Technical Resources. BD Immunocytometry Systems. FastImmune Intracellular Cytokine Staining Procedures

Technical Resources. BD Immunocytometry Systems. FastImmune Intracellular Cytokine Staining Procedures FastImmune Intracellular Cytokine Staining Procedures BD has developed protocols for the detection of intracellular cytokines in activated lymphocytes and in activated monocytes. The procedures have been

More information

Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19 Introduction(1) After AMI all

More information

Human and mouse T cell regulation mediated by soluble CD52 interaction with Siglec-10. Esther Bandala-Sanchez, Yuxia Zhang, Simone Reinwald,

Human and mouse T cell regulation mediated by soluble CD52 interaction with Siglec-10. Esther Bandala-Sanchez, Yuxia Zhang, Simone Reinwald, Human and mouse T cell regulation mediated by soluble CD52 interaction with Siglec-1 Esther Bandala-Sanchez, Yuxia Zhang, Simone Reinwald, James A. Dromey, Bo Han Lee, Junyan Qian, Ralph M Böhmer and Leonard

More information

CD25-PE (BD Biosciences) and labeled with anti-pe-microbeads (Miltenyi Biotec) for depletion of CD25 +

CD25-PE (BD Biosciences) and labeled with anti-pe-microbeads (Miltenyi Biotec) for depletion of CD25 + Supplements Supplemental Materials and Methods Depletion of CD25 + T-cells from PBMC. Fresh or HD precultured PBMC were stained with the conjugate CD25-PE (BD Biosciences) and labeled with anti-pe-microbeads

More information

CD90 + Human Dermal Stromal Cells Are Potent Inducers of FoxP3 + Regulatory T Cells

CD90 + Human Dermal Stromal Cells Are Potent Inducers of FoxP3 + Regulatory T Cells CD90 + Human Dermal Stromal Cells Are Potent Inducers of FoxP3 + Regulatory T Cells Karin Pfisterer, Karoline M Lipnik, Erhard Hofer and Adelheid Elbe-Bürger Journal of Investigative Dermatology (2015)

More information

Supplemental Methods. CD107a assay

Supplemental Methods. CD107a assay Supplemental Methods CD107a assay For each T cell culture that was tested, two tubes were prepared. One tube contained BCMA-K562 cells, and the other tube contained NGFR-K562 cells. Both tubes contained

More information

10.00 PBS OVA OVA+isotype antibody 8.00 OVA+anti-HMGB1. PBS Methatroline (mg/ml)

10.00 PBS OVA OVA+isotype antibody 8.00 OVA+anti-HMGB1. PBS Methatroline (mg/ml) RESEARCH ARTICLE Penh (100% of PBS) 1 PBS 8.00 +anti-hmgb1 6.00 4.00 p=0.054 Cellular & Molecular Immunology advance online publication, PBS 3.12 6.25 Methatroline (mg/ml) Neutrophil isolation and culture

More information

Dr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION

Dr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION Benjamini. Ch. 19, Pgs 379-399 Page 1 of 10 TRANSPLANTATION I. KINDS OF GRAFTS II. RELATIONSHIPS BETWEEN DONOR AND RECIPIENT Benjamini. Ch. 19, Pgs 379-399 Page 2 of 10 II.GRAFT REJECTION IS IMMUNOLOGIC

More information

Supplementary Data 1. Alanine substitutions and position variants of APNCYGNIPL. Applied in

Supplementary Data 1. Alanine substitutions and position variants of APNCYGNIPL. Applied in Supplementary Data 1. Alanine substitutions and position variants of APNCYGNIPL. Applied in Supplementary Fig. 2 Substitution Sequence Position variant Sequence original APNCYGNIPL original APNCYGNIPL

More information

were isolated from the freshly drawn blood of healthy donors and ACS patients using the

were isolated from the freshly drawn blood of healthy donors and ACS patients using the Supplemental Figure 1. Quality control of CD4 + T-cell purification. CD4 + T cells were isolated from the freshly drawn blood of healthy donors and ACS patients using the RosetteSep CD4 + T Cell Enrichment

More information

Antibodies for human plasmacytoïd dendritic cells studies Dendritics SAS, 60 avenue Rockefeller, F Lyon

Antibodies for human plasmacytoïd dendritic cells studies Dendritics SAS, 60 avenue Rockefeller, F Lyon Antibodies for human plasmacytoïd dendritic cells studies Dendritics SAS, 60 avenue Rockefeller, F-69008 Lyon www.dendritics.net Human plasmacytoïd dendritic cells (PDCs) are considered the main sentinels

More information

Sipper BK Experimental Animal Co. (Shanghai, China) and bred in a specific. pathogen-free environment. The animal study protocol was approved by the

Sipper BK Experimental Animal Co. (Shanghai, China) and bred in a specific. pathogen-free environment. The animal study protocol was approved by the Supplementary information, Data S1 Materials and Methods Mice, Ad vectors and reagents Female C57BL/6 mice, 8-10 weeks of age, were purchased from Joint Ventures Sipper BK Experimental Animal Co. (Shanghai,

More information

Supplementary Figure 1. Efficient DC depletion in CD11c.DOG transgenic mice

Supplementary Figure 1. Efficient DC depletion in CD11c.DOG transgenic mice Supplementary Figure 1. Efficient DC depletion in CD11c.DOG transgenic mice (a) CD11c.DOG transgenic mice (tg) were treated with 8 ng/g body weight (b.w.) diphtheria toxin (DT) i.p. on day -1 and every

More information

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14- 1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish

More information

Adaptive immune responses: T cell-mediated immunity

Adaptive immune responses: T cell-mediated immunity MICR2209 Adaptive immune responses: T cell-mediated immunity Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will discuss the T-cell mediated immune response, how it is activated,

More information

Supplemental Information. T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism

Supplemental Information. T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism Immunity, Volume 33 Supplemental Information T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism Franziska Petermann, Veit Rothhammer, Malte

More information

Essential Medium, containing 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin. Huvec were cultured in

Essential Medium, containing 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin. Huvec were cultured in Supplemental data Methods Cell culture media formulations A-431 and U-87 MG cells were maintained in Dulbecco s Modified Eagle s Medium. FaDu cells were cultured in Eagle's Minimum Essential Medium, containing

More information

TITLE: MODULATION OF T CELL TOLERANCE IN A MURINE MODEL FOR IMMUNOTHERAPY OF PROSTATIC ADENOCARCINOMA

TITLE: MODULATION OF T CELL TOLERANCE IN A MURINE MODEL FOR IMMUNOTHERAPY OF PROSTATIC ADENOCARCINOMA AD Award Number: DAMD17-01-1-0085 TITLE: MODULATION OF T CELL TOLERANCE IN A MURINE MODEL FOR IMMUNOTHERAPY OF PROSTATIC ADENOCARCINOMA PRINCIPAL INVESTIGATOR: ARTHUR A HURWITZ, Ph.d. CONTRACTING ORGANIZATION:

More information

DISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS

DISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS DISCOVERING ATCC IMMUNOLOGICAL CELLS - MODEL SYSTEMS TO STUDY THE IMMUNE AND CARDIOVASCULAR SYSTEMS James Clinton, Ph.D. Scientist, ATCC February 19, 2015 About ATCC Founded in 1925, ATCC is a non-profit

More information

Human Umbilical Vein Endothelial Cell Manual

Human Umbilical Vein Endothelial Cell Manual Human Umbilical Vein Endothelial Cell Manual INSTRUCTION MANUAL ZBM0079.03 SHIPPING CONDITIONS Human Umbilical Vein Endothelial Cells, cryopreserved Cryopreserved cells are shipped on dry ice and should

More information

Naive, memory and regulatory T lymphocytes populations analysis

Naive, memory and regulatory T lymphocytes populations analysis Naive, memory and regulatory T lymphocytes populations analysis Jaen Olivier, PhD ojaen@beckmancoulter.com Cellular Analysis application specialist Beckman Coulter France Introduction Flow cytometric analysis

More information

The Adaptive Immune Responses

The Adaptive Immune Responses The Adaptive Immune Responses The two arms of the immune responses are; 1) the cell mediated, and 2) the humoral responses. In this chapter we will discuss the two responses in detail and we will start

More information

Endothelial progenitor cells (EPCs) are

Endothelial progenitor cells (EPCs) are Separation and identification of endothelial progenitor cells from rat peripheral blood Si-Lin Pan, Quan-Sheng Xing, Long Sun Qingdao, China 50 Background: Kawasaki disease (KD) as the most commonly acquired

More information

Annals of West University of Timisoara

Annals of West University of Timisoara Annals of West University of Timisoara Series of Chemistry 20 (2) (2011) 45-52 FICOLL DENSITY GRADIENT ISOLATION METHOD VS. DIRECT FLOW CYTOMETRIC QUANTIFICATION OF EPCS Cristiana Bujor a, A. Anghel a,

More information

Supplemental Experimental Procedures

Supplemental Experimental Procedures Cell Stem Cell, Volume 2 Supplemental Data A Temporal Switch from Notch to Wnt Signaling in Muscle Stem Cells Is Necessary for Normal Adult Myogenesis Andrew S. Brack, Irina M. Conboy, Michael J. Conboy,

More information

Supplementary Information

Supplementary Information Supplementary Information Supplementary Figure 1. CD4 + T cell activation and lack of apoptosis after crosslinking with anti-cd3 + anti-cd28 + anti-cd160. (a) Flow cytometry of anti-cd160 (5D.10A11) binding

More information

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer AD Award Number: W8-XWH-5-- TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer PRINCIPAL INVESTIGATOR: Mathias Oelke, Ph.D. CONTRACTING ORGANIZATION: Johns Hopkins

More information

SUPPLEMENT Supplementary Figure 1: (A) (B)

SUPPLEMENT Supplementary Figure 1: (A) (B) SUPPLEMENT Supplementary Figure 1: CD4 + naïve effector T cells (CD4 effector) were labeled with CFSE, stimulated with α-cd2/cd3/cd28 coated beads (at 2 beads/cell) and cultured alone or cocultured with

More information

NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies

NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies Saul Kivimäe Senior Scientist, Research Biology Nektar Therapeutics NK Cell-Based Cancer Immunotherapy, September 26-27,

More information

Supplemental Information. Tissue Myeloid Progenitors Differentiate. into Pericytes through TGF-b Signaling. in Developing Skin Vasculature

Supplemental Information. Tissue Myeloid Progenitors Differentiate. into Pericytes through TGF-b Signaling. in Developing Skin Vasculature Cell Reports, Volume 18 Supplemental Information Tissue Myeloid Progenitors Differentiate into Pericytes through TGF-b Signaling in Developing Skin Vasculature Tomoko Yamazaki, Ani Nalbandian, Yutaka Uchida,

More information

Protocol for Gene Transfection & Western Blotting

Protocol for Gene Transfection & Western Blotting The schedule and the manual of basic techniques for cell culture Advanced Protocol for Gene Transfection & Western Blotting Schedule Day 1 26/07/2008 Transfection Day 3 28/07/2008 Cell lysis Immunoprecipitation

More information

Effector T Cells and

Effector T Cells and 1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New

More information

T Cell Activation, Costimulation and Regulation

T Cell Activation, Costimulation and Regulation 1 T Cell Activation, Costimulation and Regulation Abul K. Abbas, MD University of California San Francisco 2 Lecture outline T cell antigen recognition and activation Costimulation, the B7:CD28 family

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature10134 Supplementary Figure 1. Anti-inflammatory activity of sfc. a, Autoantibody immune complexes crosslink activating Fc receptors, promoting activation of macrophages, and WWW.NATURE.COM/NATURE

More information

Cytokines, adhesion molecules and apoptosis markers. A comprehensive product line for human and veterinary ELISAs

Cytokines, adhesion molecules and apoptosis markers. A comprehensive product line for human and veterinary ELISAs Cytokines, adhesion molecules and apoptosis markers A comprehensive product line for human and veterinary ELISAs IBL International s cytokine product line... is extremely comprehensive. The assays are

More information

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier Micro 204 Cytotoxic T Lymphocytes (CTL) Lewis Lanier Lewis.Lanier@ucsf.edu Lymphocyte-mediated Cytotoxicity CD8 + αβ-tcr + T cells CD4 + αβ-tcr + T cells γδ-tcr + T cells Natural Killer cells CD8 + αβ-tcr

More information

Bioassays for Quality Control of Cell & Gene Therapy Products

Bioassays for Quality Control of Cell & Gene Therapy Products Bioassays for Quality Control of Cell & Gene Therapy Products Erik Rutjens, Cell & Gene Therapy, Novartis Pharma AG CASSS Bioassays, Silver Spring, March2015 CTL019 Introduction CARTs = Chimeric Antigen

More information

Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells

Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells This information is current as of May 2, 2018. Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells Xinming Su, Jian Ye, Eddy C. Hsueh, Yanping Zhang, Daniel F. Hoft and Guangyong

More information

Endothelial Progenitor Cell Dysfunction: a Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes

Endothelial Progenitor Cell Dysfunction: a Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes Chapter3 Endothelial Progenitor Cell Dysfunction: a Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes Cindy J.M. Loomans 1, Eelco J.P. de Koning 1, Frank J.T. Staal 2, Maarten

More information

Supplementary Figure 1. H-PGDS deficiency does not affect GI tract functions and anaphylactic reaction. (a) Representative pictures of H&E-stained

Supplementary Figure 1. H-PGDS deficiency does not affect GI tract functions and anaphylactic reaction. (a) Representative pictures of H&E-stained 1 2 3 4 5 6 7 8 9 10 11 Supplementary Figure 1. H-PGDS deficiency does not affect GI tract functions and anaphylactic reaction. (a) Representative pictures of H&E-stained jejunum sections ( 200 magnification;

More information

Third line of Defense

Third line of Defense Chapter 15 Specific Immunity and Immunization Topics -3 rd of Defense - B cells - T cells - Specific Immunities Third line of Defense Specific immunity is a complex interaction of immune cells (leukocytes)

More information

Subject Index. Bcl-2, apoptosis regulation Bone marrow, polymorphonuclear neutrophil release 24, 26

Subject Index. Bcl-2, apoptosis regulation Bone marrow, polymorphonuclear neutrophil release 24, 26 Subject Index A1, apoptosis regulation 217, 218 Adaptive immunity, polymorphonuclear neutrophil role 31 33 Angiogenesis cancer 178 endometrium remodeling 172 HIV Tat induction mechanism 176 inflammatory

More information

W/T Itgam -/- F4/80 CD115. F4/80 hi CD115 + F4/80 + CD115 +

W/T Itgam -/- F4/80 CD115. F4/80 hi CD115 + F4/80 + CD115 + F4/8 % in the peritoneal lavage 6 4 2 p=.15 n.s p=.76 CD115 F4/8 hi CD115 + F4/8 + CD115 + F4/8 hi CD115 + F4/8 + CD115 + MHCII MHCII Supplementary Figure S1. CD11b deficiency affects the cellular responses

More information

Vascular injury leads to pathological repair and remodeling

Vascular injury leads to pathological repair and remodeling Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured Arteries Deling Kong, PhD; Luis G. Melo, PhD; Massimiliano Gnecchi, MD; Lunan Zhang, MD; Gustavo Mostoslavsky,

More information

Journal Club Semmler Lorenz

Journal Club Semmler Lorenz Beer et al. 2015 - Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration Journal Club 13.11.2017 1 Introduction to

More information

Product Datasheet. CD133 Antibody NB Unit Size: 0.1 mg

Product Datasheet. CD133 Antibody NB Unit Size: 0.1 mg Product Datasheet CD133 Antibody NB120-16518 Unit Size: 0.1 mg Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. Publications: 8 Protocols, Publications, Related Products,

More information

Nature Medicine: doi: /nm.3922

Nature Medicine: doi: /nm.3922 Title: Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells Authors: Il-Kyu Kim, Byung-Seok Kim, Choong-Hyun

More information

Supplementary Data Table of Contents:

Supplementary Data Table of Contents: Supplementary Data Table of Contents: - Supplementary Methods - Supplementary Figures S1(A-B) - Supplementary Figures S2 (A-B) - Supplementary Figures S3 - Supplementary Figures S4(A-B) - Supplementary

More information

Data Sheet IL-2-Luciferase Reporter (Luc) - Jurkat Cell Line Catalog # 60481

Data Sheet IL-2-Luciferase Reporter (Luc) - Jurkat Cell Line Catalog # 60481 642 Cornerstone Court W, Ste B Tel: 1.858.829.382 Data Sheet IL-2-Luciferase Reporter (Luc) - Jurkat Cell Line Catalog # 6481 Description Human IL-2 reporter construct is stably integrated into the genome

More information

Cytokine Complex Expanded Natural Killer Cells Improve Allogeneic Lung. Transplant Function via Depletion of Donor Dendritic Cells

Cytokine Complex Expanded Natural Killer Cells Improve Allogeneic Lung. Transplant Function via Depletion of Donor Dendritic Cells Cytokine Complex Expanded Natural Killer Cells Improve Allogeneic Lung Transplant Function via Depletion of Donor Dendritic Cells Wolfgang Jungraithmayr, Laura Codarri, Gregory Bouchaud,Carsten Krieg,

More information

Supplementalgfigureg1gSchematicgdiagramgofgtumor1modellingg

Supplementalgfigureg1gSchematicgdiagramgofgtumor1modellingg SChinjectionh F:LuchLCLsh IVhinjectionh T:cellsh Monitorhforhtumorh growthhandhxeno: reactivehgvhd GVLgexperimentg kcbgvsgpbgt1cellse Xeno1reactiveg experimentg kcbgvsgpbgt1cellse IVhinjectionh 5xh,N^6

More information

Supplementary Figure 1. Enhanced detection of CTLA-4 on the surface of HIV-specific

Supplementary Figure 1. Enhanced detection of CTLA-4 on the surface of HIV-specific SUPPLEMENTARY FIGURE LEGEND Supplementary Figure 1. Enhanced detection of CTLA-4 on the surface of HIV-specific CD4 + T cells correlates with intracellular CTLA-4 levels. (a) Comparative CTLA-4 levels

More information

Canberra, Australia). CD11c-DTR-OVA-GFP (B6.CD11c-OVA), B6.luc + and. Cancer Research Center, Germany). B6 or BALB/c.FoxP3-DTR-GFP mice were

Canberra, Australia). CD11c-DTR-OVA-GFP (B6.CD11c-OVA), B6.luc + and. Cancer Research Center, Germany). B6 or BALB/c.FoxP3-DTR-GFP mice were Supplemental Materials and Methods Mice Female C57BL/6 (B6, I-E null, H-2 b ), BALB/c (H-2 d ) + ), FVB/N (H-2 q, I-E null, CD45.1 + ), and B6D2F1 (H-2 b/d ) mice were purchased from the Animal Resources

More information

Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell?

Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? Abbas Chapter 2: Sarah Spriet February 8, 2015 Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? a. Dendritic cells b. Macrophages c. Monocytes

More information

Applications for the MACSQuant Analyzer *

Applications for the MACSQuant Analyzer * For research use only Enumeration of CD34/CD133 positive cells with the CD34/CD133 Enumeration Kit Applications for the MACSQuant Analyzer * Background The CD34 antigen is a single-chain transmembrane

More information